Analysis of Reportable Segments
Baxter International Inc. operates in 2 segments: Renal and Hospital Products.
Segment Profit Margin
Baxter International Inc., profit margin by reportable segment
| Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | |
|---|---|---|---|---|---|
| Renal | 14.94% | 15.96% | 21.69% | — | — |
| Hospital Products | 32.34% | 34.17% | 35.45% | — | — |
Based on: 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).
| Segment profitability ratio | Reportable segment | The company |
|---|---|---|
| Segment profit margin | Renal | Renal segment profit margin ratio deteriorated from 2013 to 2014 and from 2014 to 2015. |
| Hospital Products | Hospital Products segment profit margin ratio deteriorated from 2013 to 2014 and from 2014 to 2015. |
Segment Profit Margin: Renal
Baxter International Inc.; Renal; segment profit margin calculation
| Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||
| EBITDA | 566) | 666) | 670) | —) | —) |
| Net sales | 3,789) | 4,172) | 3,089) | —) | —) |
| Segment Profitability Ratio | |||||
| Segment profit margin1 | 14.94% | 15.96% | 21.69% | — | — |
Based on: 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).
1 2015 Calculation
Segment profit margin = 100 × EBITDA ÷ Net sales
= 100 × 566 ÷ 3,789 = 14.94%
| Segment profitability ratio | Reportable segment | The company |
|---|---|---|
| Segment profit margin | Renal | Renal segment profit margin ratio deteriorated from 2013 to 2014 and from 2014 to 2015. |
Segment Profit Margin: Hospital Products
Baxter International Inc.; Hospital Products; segment profit margin calculation
| Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||
| EBITDA | 1,998) | 2,237) | 2,242) | —) | —) |
| Net sales | 6,179) | 6,547) | 6,324) | —) | —) |
| Segment Profitability Ratio | |||||
| Segment profit margin1 | 32.34% | 34.17% | 35.45% | — | — |
Based on: 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).
1 2015 Calculation
Segment profit margin = 100 × EBITDA ÷ Net sales
= 100 × 1,998 ÷ 6,179 = 32.34%
| Segment profitability ratio | Reportable segment | The company |
|---|---|---|
| Segment profit margin | Hospital Products | Hospital Products segment profit margin ratio deteriorated from 2013 to 2014 and from 2014 to 2015. |
Segment Return on Assets (Segment ROA)
Baxter International Inc., ROA by reportable segment
| Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | |
|---|---|---|---|---|---|
| Renal | 12.28% | 13.51% | 12.24% | — | — |
| Hospital Products | 30.13% | 32.35% | 31.85% | — | — |
Based on: 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).
| Segment profitability ratio | Reportable segment | The company |
|---|---|---|
| Segment ROA | Renal | Renal segment ROA improved from 2013 to 2014 but then slightly deteriorated from 2014 to 2015 not reaching 2013 level. |
| Hospital Products | Hospital Products segment ROA improved from 2013 to 2014 but then deteriorated significantly from 2014 to 2015. |
Segment ROA: Renal
Baxter International Inc.; Renal; segment ROA calculation
| Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||
| EBITDA | 566) | 666) | 670) | —) | —) |
| Total assets | 4,609) | 4,928) | 5,475) | —) | —) |
| Segment Profitability Ratio | |||||
| Segment ROA1 | 12.28% | 13.51% | 12.24% | — | — |
Based on: 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).
1 2015 Calculation
Segment ROA = 100 × EBITDA ÷ Total assets
= 100 × 566 ÷ 4,609 = 12.28%
| Segment profitability ratio | Reportable segment | The company |
|---|---|---|
| Segment ROA | Renal | Renal segment ROA improved from 2013 to 2014 but then slightly deteriorated from 2014 to 2015 not reaching 2013 level. |
Segment ROA: Hospital Products
Baxter International Inc.; Hospital Products; segment ROA calculation
| Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||
| EBITDA | 1,998) | 2,237) | 2,242) | —) | —) |
| Total assets | 6,632) | 6,915) | 7,039) | —) | —) |
| Segment Profitability Ratio | |||||
| Segment ROA1 | 30.13% | 32.35% | 31.85% | — | — |
Based on: 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).
1 2015 Calculation
Segment ROA = 100 × EBITDA ÷ Total assets
= 100 × 1,998 ÷ 6,632 = 30.13%
| Segment profitability ratio | Reportable segment | The company |
|---|---|---|
| Segment ROA | Hospital Products | Hospital Products segment ROA improved from 2013 to 2014 but then deteriorated significantly from 2014 to 2015. |
Segment Asset Turnover
Baxter International Inc., asset turnover by reportable segment
| Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | |
|---|---|---|---|---|---|
| Renal | 0.82 | 0.85 | 0.56 | — | — |
| Hospital Products | 0.93 | 0.95 | 0.90 | — | — |
Based on: 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).
| Segment activity ratio | Reportable segment | The company |
|---|---|---|
| Segment asset turnover | Renal | Renal segment asset turnover ratio improved from 2013 to 2014 but then slightly deteriorated from 2014 to 2015. |
| Hospital Products | Hospital Products segment asset turnover ratio improved from 2013 to 2014 but then slightly deteriorated from 2014 to 2015. |
Segment Asset Turnover: Renal
Baxter International Inc.; Renal; segment asset turnover calculation
| Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||
| Net sales | 3,789) | 4,172) | 3,089) | —) | —) |
| Total assets | 4,609) | 4,928) | 5,475) | —) | —) |
| Segment Activity Ratio | |||||
| Segment asset turnover1 | 0.82 | 0.85 | 0.56 | — | — |
Based on: 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).
1 2015 Calculation
Segment asset turnover = Net sales ÷ Total assets
= 3,789 ÷ 4,609 = 0.82
| Segment activity ratio | Reportable segment | The company |
|---|---|---|
| Segment asset turnover | Renal | Renal segment asset turnover ratio improved from 2013 to 2014 but then slightly deteriorated from 2014 to 2015. |
Segment Asset Turnover: Hospital Products
Baxter International Inc.; Hospital Products; segment asset turnover calculation
| Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||
| Net sales | 6,179) | 6,547) | 6,324) | —) | —) |
| Total assets | 6,632) | 6,915) | 7,039) | —) | —) |
| Segment Activity Ratio | |||||
| Segment asset turnover1 | 0.93 | 0.95 | 0.90 | — | — |
Based on: 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).
1 2015 Calculation
Segment asset turnover = Net sales ÷ Total assets
= 6,179 ÷ 6,632 = 0.93
| Segment activity ratio | Reportable segment | The company |
|---|---|---|
| Segment asset turnover | Hospital Products | Hospital Products segment asset turnover ratio improved from 2013 to 2014 but then slightly deteriorated from 2014 to 2015. |
Net sales
Baxter International Inc., net sales by reportable segment
US$ in millions
| Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | |
|---|---|---|---|---|---|
| Renal | 3,789) | 4,172) | 3,089) | —) | —) |
| Hospital Products | 6,179) | 6,547) | 6,324) | —) | —) |
| Total | 9,968) | 10,719) | 9,413) | —) | —) |
Based on: 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).
EBITDA
Baxter International Inc., ebitda by reportable segment
US$ in millions
| Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | |
|---|---|---|---|---|---|
| Renal | 566) | 666) | 670) | —) | —) |
| Hospital Products | 1,998) | 2,237) | 2,242) | —) | —) |
| Total | 2,564) | 2,903) | 2,912) | —) | —) |
Based on: 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).
Total assets
Baxter International Inc., total assets by reportable segment
US$ in millions
| Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | |
|---|---|---|---|---|---|
| Renal | 4,609) | 4,928) | 5,475) | —) | —) |
| Hospital Products | 6,632) | 6,915) | 7,039) | —) | —) |
| Total | 11,241) | 11,843) | 12,514) | —) | —) |
Based on: 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).